the effect of a new dopamine receptor stimulating agent , piribedil ( et 495 ) , was studied in 10 patients with parkinson 's syndrome , who had had no or a poor response to previous l-dopa treatment , or had displayed marked side effects during l-dopa administration .
C0030567
parkinson 's syndrome
C0023570
l-dopa